EUR 0.87
(-3.89%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -11.86 Million EUR | -27.39% |
2022 | -9.31 Million EUR | -83.94% |
2021 | -5.06 Million EUR | -235.64% |
2020 | 3.73 Million EUR | 97.67% |
2019 | 1.88 Million EUR | -17.45% |
2018 | 2.28 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -1.87 Million EUR | 53.37% |
2024 Q2 | -1.94 Million EUR | -4.11% |
2024 Q3 | -1.96 Million EUR | -0.92% |
2023 FY | -11.86 Million EUR | -27.39% |
2023 Q4 | -4.01 Million EUR | 0.0% |
2023 Q1 | -1.73 Million EUR | 16.83% |
2023 Q3 | -4.01 Million EUR | -91.83% |
2023 Q2 | -2.09 Million EUR | -20.36% |
2022 Q3 | -2.09 Million EUR | 43.16% |
2022 Q4 | -2.09 Million EUR | 0.0% |
2022 FY | -9.31 Million EUR | -83.94% |
2022 Q2 | -3.67 Million EUR | -68.38% |
2022 Q1 | -2.18 Million EUR | 48.47% |
2021 Q4 | -4.24 Million EUR | -49.14% |
2021 FY | -5.06 Million EUR | -235.64% |
2021 Q3 | -2.84 Million EUR | -347.22% |
2021 Q2 | 1.15 Million EUR | 13.75% |
2021 Q1 | 1.01 Million EUR | -49.85% |
2020 Q3 | 638 Thousand EUR | 0.0% |
2020 FY | 3.73 Million EUR | 97.67% |
2020 Q4 | 2.01 Million EUR | 215.99% |
2019 FY | 1.88 Million EUR | -17.45% |
2018 FY | 2.28 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | -3.48 Million EUR | -240.48% |
Nexstim Plc | -1.32 Million EUR | -793.473% |
Revenio Group Oyj | 19.1 Million EUR | 162.07% |